{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:02:03Z","timestamp":1790211723979,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41440-020-00574-1","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T09:08:39Z","timestamp":1604480919000},"page":"263-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Activation of arginase II by asymmetric dimethylarginine and homocysteine in hypertensive rats induced by hypoxia: a new model of nitric oxide synthesis regulation in hypertensive processes?"],"prefix":"10.1038","volume":"44","author":[{"given":"Vasthi","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"574_CR1","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1093\/eurheartj\/ehu275","volume":"35","author":"G Parati","year":"2014","unstructured":"Parati G, Bilo G, Faini A. Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial. Eur Heart J. 2014;35:3113\u201322.","journal-title":"Eur Heart J"},{"key":"574_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fphys.2018.00187","volume":"23","author":"FA Moraga","year":"2018","unstructured":"Moraga FA, L\u00f3pez I, Morales A, Soza D, Noack J. The effect of oxygen enrichment on cardiorespiratory and neuropsychological responses in workers with chronic intermittent exposure to high altitude (ALMA, 5,050 m). Front Physiol. 2018;23:187. 9","journal-title":"Front Physiol"},{"key":"574_CR3","doi-asserted-by":"crossref","first-page":"e007026","DOI":"10.1136\/bmjopen-2014-007026","volume":"5","author":"T Norboo","year":"2015","unstructured":"Norboo T, Stobdan T, Tsering N, Angchuk N, Tsering P, Ahmed I, et al. Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India. BMJ Open. 2015;5:e007026.","journal-title":"BMJ Open."},{"key":"574_CR4","first-page":"21","volume":"60","author":"PC Negi","year":"2012","unstructured":"Negi PC, Bhardwaj R, Kandoria A, Asotra S, Ganju N, Marwaha R, et al. Epidemiological study of hypertension in natives of Spiti Valley in Himalayas and impact of hypobaric hypoxemia; a cross-sectional study. J Assoc Physicians India. 2012;60:21\u20135.","journal-title":"J Assoc Physicians India"},{"key":"574_CR5","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/01.CIR.96.4.1224","volume":"96","author":"BD Levine","year":"1997","unstructured":"Levine BD, Zuckerman JH, de Filippi CR. Effect of high-altitude exposure in the elderly: the tenth mountain division study. Circulation. 1997;96:1224\u201332.","journal-title":"Circulation"},{"key":"574_CR6","doi-asserted-by":"crossref","unstructured":"Baggish AL, Wolfel EE, Levine BD. Cardiovascular system. In: Swenson ER, Bartsch P, editors. High altitude: human adaptation to hypoxia. New York: Springer; 2014. p. 103\u201340.","DOI":"10.1007\/978-1-4614-8772-2_6"},{"key":"574_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/ham.2008.1072","volume":"10","author":"V L\u00f3pez","year":"2009","unstructured":"L\u00f3pez V, Siques P, Brito J, Vallejos C, Naveas N. Upregulation of arginase expression and activity in hypertensive rats exposed to chronic intermittent hypobaric hypoxia. High Alt Med Biol. 2009;10:373\u201381.","journal-title":"High Alt Med Biol"},{"key":"574_CR8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/HCO.0b013e3281ca710d","volume":"22","author":"U Landmesser","year":"2007","unstructured":"Landmesser U, Drexler H. Endothelial function and hypertension. Curr Opin Cardiol. 2007;22:316\u201320.","journal-title":"Curr Opin Cardiol"},{"key":"574_CR9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00005344-199912000-00016","volume":"34","author":"LJ Ignarro","year":"1999","unstructured":"Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharm. 1999;34:879\u201386.","journal-title":"J Cardiovasc Pharm"},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","volume":"188","author":"JR Klinger","year":"2013","unstructured":"Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188:639\u201346.","journal-title":"Am J Respir Crit Care Med"},{"key":"574_CR11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.CIR.0000051466.00227.13","volume":"107","author":"FI Arrigoni","year":"2003","unstructured":"Arrigoni FI, Vallance P, Haworth SG, Leiper JM. Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation. 2003;107:1195\u2013201.","journal-title":"Circulation"},{"key":"574_CR12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1096\/fj.04-3223fje","volume":"19","author":"S Pullamsetti","year":"2005","unstructured":"Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P. Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J. 2005;19:1175\u20137.","journal-title":"FASEB J"},{"key":"574_CR13","doi-asserted-by":"crossref","first-page":"L1480","DOI":"10.1152\/ajplung.00360.2006","volume":"292","author":"A Sasaki","year":"2007","unstructured":"Sasaki A, Doi S, Mizutani S, Azuma H. Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1480\u20137.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"574_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3132\/dvdr.2007.033","volume":"4","author":"AS Wierzbicki","year":"2007","unstructured":"Wierzbicki AS. Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res. 2007;4:143\u201350.","journal-title":"Diab Vasc Dis Res"},{"key":"574_CR15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3760\/cma.j.issn.0366-6999.20132694","volume":"127","author":"L Sun","year":"2014","unstructured":"Sun L, Sun S, Li Y, Pan W, Xie Y. Potential biomarkers predicting risk of pulmonary hypertension in congenital heart disease: the role of homocysteine and hydrogen sulfide. Chin Med J. 2014;127:893\u20139.","journal-title":"Chin Med J"},{"key":"574_CR16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","volume":"60","author":"RH B\u00f6ger","year":"2009","unstructured":"B\u00f6ger RH, Maas R, Schulze F, Schwedhelm E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-an update on patient populations with a wide range of cardiovascular risk. Pharm Res. 2009;60:481\u20137.","journal-title":"Pharm Res"},{"key":"574_CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/ham.2016.0123","volume":"18","author":"N L\u00fcneburg","year":"2017","unstructured":"L\u00fcneburg N, Siques P, Brito J, De La Cruz JJ, Le\u00f3n-Velarde F, Hannemann J, et al. Long-term intermittent exposure to high altitude elevates asymmetric dimethylarginine in first exposed young adults. High Alt Med Biol. 2017;18:226\u201333.","journal-title":"High Alt Med Biol"},{"key":"574_CR18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3389\/fphys.2019.00651","volume":"27","author":"P Siques","year":"2019","unstructured":"Siques P, Brito J, Schwedhelm E, Pena E, Le\u00f3n-Velarde F, De La Cruz JJ, et al. Asymmetric dimethylarginine at sea level is a predictive marker of hypoxic pulmonary arterial hypertension at high altitude. Front Physiol. 2019;27:651.","journal-title":"Front Physiol"},{"key":"574_CR19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fphys.2018.00606","volume":"29","author":"V L\u00f3pez","year":"2018","unstructured":"L\u00f3pez V, Moraga FA, Llanos AJ, Ebensperger G, Taborda MI, Uribe E. Plasmatic concentrations of ADMA and Homocystein in Llama (Lama glama) and Regulation of Arginase Type II: an animal resistent to the development of pulmonary hypertension induced by hypoxia. Front Physiol. 2018;29:606.","journal-title":"Front Physiol"},{"key":"574_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1567-5688(03)00032-1","volume":"4","author":"CT Tran","year":"2003","unstructured":"Tran CT, Leiper JM, Vallance P. The DDAH\/ADMA\/NOS pathway. Atheroscler Suppl. 2003;4:33\u201340.","journal-title":"Atheroscler Suppl"},{"key":"574_CR21","doi-asserted-by":"crossref","first-page":"33934","DOI":"10.1038\/srep33934","volume":"6","author":"C Xuan","year":"2016","unstructured":"Xuan C, Xu LQ, Tian QW, Li H, Wang Q, He GW et al. Dimethylarginine dimethylaminohydrolase 2 (DDAH 2) gene polymorphism, asymmetric dimethylarginine (ADMA) concentrations, and risk of coronary artery disease: a case-control study. Sci Rep. 2016;6:33934.","journal-title":"Sci Rep"},{"key":"574_CR22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2011.08.029","volume":"312","author":"R Ding","year":"2012","unstructured":"Ding R, Lin S, Chen D. The association of cystathionine \u03b2 synthase (CBS) T833C polymorphism and the risk of stroke: a meta-analysis. J Neurol Sci 2012;312:26\u201330.","journal-title":"J Neurol Sci"},{"key":"574_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvt036","volume":"98","author":"J Pernow","year":"2013","unstructured":"Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res. 2013;98:334\u201343.","journal-title":"Cardiovasc Res"},{"key":"574_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1681.2006.04316.x","volume":"33","author":"NN Huynh","year":"2006","unstructured":"Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharm Physiol. 2006;33:1\u20138.","journal-title":"Clin Exp Pharm Physiol"},{"key":"574_CR25","doi-asserted-by":"crossref","first-page":"2842S","DOI":"10.1093\/jn\/134.10.2842S","volume":"134","author":"RH Boger","year":"2004","unstructured":"Boger RH. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u201cL-arginine paradox\u201d and acts as a novel cardiovascular risk factor. J Nutr. 2004;134:2842S\u20137S.","journal-title":"J Nutr"},{"key":"574_CR26","doi-asserted-by":"crossref","first-page":"R1057","DOI":"10.1152\/ajpregu.00758.2004","volume":"288","author":"FK Johnson","year":"2005","unstructured":"Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1057\u201362.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"574_CR27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2007.128959","volume":"581","author":"LA Holowatz","year":"2007","unstructured":"Holowatz LA, Kenney WL. Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans. J Physiol. 2007;581:863\u201372.","journal-title":"J Physiol"},{"key":"574_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vph.2009.09.005","volume":"51","author":"S Sharma","year":"2009","unstructured":"Sharma S, Kumar S, Sud N, Wiseman DA, Tian J. Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow. Vasc Pharm. 2009;51:359\u201364.","journal-title":"Vasc Pharm"},{"key":"574_CR29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/clinchem\/3.2.102","volume":"3","author":"RM Archibald","year":"1957","unstructured":"Archibald RM. Colorimetric measurement of uric acid. Clin Chem. 1957;3:102\u20135.","journal-title":"Clin Chem"},{"key":"574_CR30","first-page":"400","volume":"40","author":"G Venkatakrishnan","year":"2003","unstructured":"Venkatakrishnan G, Shankar V, Reddy SR. Microheterogeneity of molecular forms of arginase in mammalian tissues. Indian J Biochem Biophys. 2003;40:400\u20138.","journal-title":"Indian J Biochem Biophys"},{"key":"574_CR31","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248\u201354.","journal-title":"Anal Biochem"},{"key":"574_CR32","unstructured":"Bredt DS, Schmidt HW. The citrulline assay, in methods in nitric oxide research. John Wiley & Sons: New York; 1996. p. 249\u201355."},{"key":"574_CR33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cvr\/cvm013","volume":"77","author":"EA Herrera","year":"2008","unstructured":"Herrera EA, Reyes RV, Giussani DA, Riquelme RA, Sanhueza EM, Ebensperger G, et al. Carbon monoxide: a novel pulmonary artery vasodilator in neonatal llamas of the Andean altiplano. Cardiovasc Res. 2008;77:197\u2013201.","journal-title":"Cardiovasc Res"},{"key":"574_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005344-200104000-00016","volume":"37","author":"M Gorenflo","year":"2001","unstructured":"Gorenflo M, Zheng C, Werle E, Fiehn W, Ulmer HE. Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharm. 2001;37:489\u201393.","journal-title":"J Cardiovasc Pharm"},{"key":"574_CR35","doi-asserted-by":"crossref","first-page":"493.e1","DOI":"10.1016\/j.ahj.2006.06.005","volume":"152","author":"F Schulze","year":"2006","unstructured":"Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J. 2006;152:493.e1\u20138.","journal-title":"Am Heart J"},{"key":"574_CR36","first-page":"9430","volume":"18","author":"SL Jawalekar","year":"2013","unstructured":"Jawalekar SL, Karnik A, Bhutey A. Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine. Biochem Res Int. 2013;18:9430.","journal-title":"Biochem Res Int"},{"key":"574_CR37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.hjr.0000230108.86147.40","volume":"14","author":"C Iribarren","year":"2007","unstructured":"Iribarren C, Husson G, Sydow K, Wang BY, Sidney S. Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study. Eur J Cardiovasc Prev Rehabil. 2007;14:222\u20139.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"574_CR38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1590\/S1807-59322009000500015","volume":"64","author":"MB Landim","year":"2009","unstructured":"Landim MB, Casella Filho A, Chagas AC. Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis. Clinics. 2009;64:471\u20138.","journal-title":"Clinics"},{"key":"574_CR39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17305\/bjbms.2014.2291","volume":"14","author":"A Zaciragic","year":"2014","unstructured":"Zaciragic A, Huskic J, Mulabegovic N, Avdagic N, Valjevac A. An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus. Bosn J Basic Med Sci. 2014;14:21\u20134.","journal-title":"Bosn J Basic Med Sci"},{"key":"574_CR40","first-page":"818037","volume":"2013;","author":"D Spasovski","year":"2013","unstructured":"Spasovski D, Latifi A, Osmani B, Krstevska-Balkanov S, Kafedizska I. Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis. Arthritis. 2013;2013:818037.","journal-title":"Arthritis"},{"key":"574_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.niox.2013.07.006","volume":"33","author":"PN Alpoim","year":"2013","unstructured":"Alpoim PN, Godoi LC, Freitas LG, Gomes KB, Dusse LM. Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia. Nitric Oxide. 2013;33:81\u20132.","journal-title":"Nitric Oxide"},{"key":"574_CR42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11883-006-0046-4","volume":"8","author":"S Guthikonda","year":"2006","unstructured":"Guthikonda S, Haynes WG. Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep. 2006;8:100\u20136.","journal-title":"Curr Atheroscler Rep"},{"key":"574_CR43","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.HYP.0000127914.94292.76","volume":"43","author":"T Suhara","year":"2004","unstructured":"Suhara T, Fukuo K, Yasuda O, Tsubakimoto M, Takemura Y. Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways. Hypertension. 2004;43:1208\u201313.","journal-title":"Hypertension"},{"key":"574_CR44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5604\/17322693.1087521","volume":"68","author":"A Baszczuk","year":"2014","unstructured":"Baszczuk A, Kopczynski Z, Thielemann A. Endothelial dysfunction in patients with primary hypertension and hyperhomocysteinemia. Postepy Hig Med Dosw. 2014;68:91\u2013100.","journal-title":"Postepy Hig Med Dosw"},{"key":"574_CR45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neulet.2009.09.035","volume":"465","author":"G Davis","year":"2009","unstructured":"Davis G, Baboolal N, Nayak S, McRae A. Sialic acid, homocysteine and CRP: potential markers for dementia. Neurosci Lett. 2009;465:282\u20134.","journal-title":"Neurosci Lett"},{"key":"574_CR46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2013.11.041","volume":"337","author":"C Cervellati","year":"2014","unstructured":"Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer\u2019s Disease or Vascular Dementia. J Neurol Sci. 2014;337:156\u201361.","journal-title":"J Neurol Sci"},{"key":"574_CR47","first-page":"309507","volume":"2014","author":"C Cervellati","year":"2014","unstructured":"Cervellati C, Romani A, Seripa D, Cremonini E, Bosi C, Magon S, et al. Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment. Biomed Res Int. 2014;2014:309507.","journal-title":"Biomed Res Int"},{"key":"574_CR48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0828-282X(07)70814-0","volume":"23","author":"J Marcus","year":"2007","unstructured":"Marcus J, Sarnak MJ, Menon V. Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol. 2007;23:707\u201310.","journal-title":"Can J Cardiol"},{"key":"574_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5830\/CVJA-2013-059","volume":"24","author":"D Sengwayo","year":"2013","unstructured":"Sengwayo D, Moraba M, Motaung S. Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity. Cardiovasc J Afr. 2013;24:265\u20139.","journal-title":"Cardiovasc J Afr"},{"key":"574_CR50","first-page":"32","volume":"5","author":"N Narayanan","year":"2013","unstructured":"Narayanan N, Tyagi N, Shah A, Pagni S, Tyagi SC. Hyperhomocysteinemia during aortic ane urysm, a plausible role of epigenetics. Int J Physiol Pathophysiol Pharm. 2013;5:32\u201342.","journal-title":"Int J Physiol Pathophysiol Pharm"},{"key":"574_CR51","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3945\/ajcn.112.044545","volume":"98","author":"JB Van Meurs","year":"2013","unstructured":"Van Meurs JB, Pare G, Schwartz SM, Hazra A, Tanaka T. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr. 2013;98:668\u201376.","journal-title":"Am J Clin Nutr"},{"key":"574_CR52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jns.2013.10.009","volume":"336","author":"M Sarov","year":"2014","unstructured":"Sarov M, Not A, de Baulny HO, Masnou P, Vahedi K. A case of homocystinuria due to CBS gene mutations revealed by cerebral venous thrombosis. J Neurol Sci. 2014;336:257\u20139.","journal-title":"J Neurol Sci"},{"key":"574_CR53","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1476-511X-13-134","volume":"21","author":"S Zhou","year":"2014","unstructured":"Zhou S, Zhang Z, Xu G. Notable epigenetic role of hyperhomocysteinemia in atherogenesis. Lipids Health Dis. 2014;21:134\u20138.","journal-title":"Lipids Health Dis"},{"key":"574_CR54","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/ajmg.a.32496","volume":"15","author":"AC Alessio","year":"2008","unstructured":"Alessio AC, Siqueira LH, Bydlowski SP, Hoehr NF, Annichino-Bizzacchi JM. Polymorphisms in the CBS gene and homocysteine, folate and vitamin B12 levels: association with polymorphisms in the MTHFR and MTRR genes in Brazilian children. Am J Med Genet. 2008;15:2598\u2013602.","journal-title":"Am J Med Genet"},{"key":"574_CR55","doi-asserted-by":"crossref","first-page":"33222","DOI":"10.1371\/journal.pone.0033222","volume":"7","author":"M Yakub","year":"2012","unstructured":"Yakub M, Moti N, Parveen S, Chaudhry B, Azam I. Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population. PLoS ONE. 2012;7:33222\u20135.","journal-title":"PLoS ONE"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-00574-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T22:06:08Z","timestamp":1723845968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-00574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-00574-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}